<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T22:36:10Z</responseDate>
  <request identifier="oai:figshare.com:article/33979246" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33979246</identifier>
        <datestamp>2026-09-24T04:29:01Z</datestamp>
        <setSpec>category_140</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary file 2_Development and internal–external validation of an interpretable machine learning model integrating clinical and polygenic predictors for coronary artery disease: a multicenter retrospective cohort study.docx</dc:title>
          <dc:creator>Fangmeng Lei (25101646)</dc:creator>
          <dc:creator>Xiangwen Xi (8906696)</dc:creator>
          <dc:creator>Zihe Dang (25101649)</dc:creator>
          <dc:creator>Shaoqing Cao (25101652)</dc:creator>
          <dc:creator>Yanqing Shen (2606146)</dc:creator>
          <dc:creator>Wenjing Hu (503593)</dc:creator>
          <dc:creator>Qiang Huang (43791)</dc:creator>
          <dc:creator>Weiwei Zhang (222964)</dc:creator>
          <dc:creator>Yanwei Yin (25101655)</dc:creator>
          <dc:creator>Wenlin Lu (25101658)</dc:creator>
          <dc:subject>Cardiology</dc:subject>
          <dc:subject>coronary artery disease</dc:subject>
          <dc:subject>explainable artificial intelligence</dc:subject>
          <dc:subject>machine learning</dc:subject>
          <dc:subject>polygenic risk score</dc:subject>
          <dc:subject>risk stratification</dc:subject>
          <dc:description>Background&lt;p&gt;Accurate primary-prevention risk stratification for coronary artery disease (CAD) remains challenging. We developed and internally validated a framework integrating clinical variables with a polygenic risk score (PRS).&lt;/p&gt;Methods&lt;p&gt;This three-center retrospective cohort included 2,067 adults without baseline CAD. The primary target was 5-year CAD cumulative incidence, with non-coronary death treated as a competing event. Clinical, PRS-only, and integrated cause-specific eXtreme Gradient Boosting (XGBoost) models were evaluated using leave-one-center-out internal–external validation. Performance assessment included cumulative/dynamic area under the curve (AUC), inverse-probability-of-censoring-weighted Brier score, calibration, and competing-risk decision-curve analysis. PRS associations were estimated using Fine–Gray regression, and model behavior was examined using SHapley Additive exPlanations (SHAP).&lt;/p&gt;Results&lt;p&gt;During a median follow-up of 6.8 years, 215 participants experienced the primary endpoint; 163 events occurred within 5 years, and the 5-year cumulative incidence was 8.4%. Each 1-SD increase in the principal component-adjusted PRS was associated with the primary endpoint (adjusted subdistribution hazard ratio, 1.37; 95% CI, 1.21–1.55; p &lt; 0.001). Based on pooled out-of-center predictions, the integrated model had a 5-year AUC of 0.779 (95% CI, 0.746–0.812), compared with 0.762 (95% CI, 0.728–0.796) for the clinical model; the difference was 0.017 (95% CI, −0.003–0.038). Its Brier score was 0.071, observed-to-expected ratio was 1.01, and calibration slope was 0.97. The integrated model showed a small net-benefit advantage over the clinical model at thresholds of approximately 8%–15%. SHAP ranked PRS, age, and low-density lipoprotein cholesterol highest and showed a concordant interaction pattern between PRS and low-density lipoprotein cholesterol. Five-year cumulative incidences were 2.7%, 7.2%, and 19.8% in the prespecified low-, intermediate-, and high-risk categories (Gray's test p &lt; 0.001).&lt;/p&gt;Conclusions&lt;p&gt;The PRS was independently associated with incident CAD. Integration with clinical variables yielded a modest, statistically uncertain improvement in discrimination and satisfactory calibration during internal–external validation. External validation is required before clinical implementation.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-24T04:29:01Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fcvm.2026.1936899.s003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_file_2_Development_and_internal_external_validation_of_an_interpretable_machine_learning_model_integrating_clinical_and_polygenic_predictors_for_coronary_artery_disease_a_multicenter_retrospective_cohort_study_docx/33979246</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
